These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

126 related items for PubMed ID: 7784339

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Oral solid controlled release dosage forms: role of GI-mechanical destructive forces and colonic release in drug absorption under fasted and fed conditions in humans.
    Shameem M, Katori N, Aoyagi N, Kojima S.
    Pharm Res; 1995 Jul; 12(7):1049-54. PubMed ID: 7494801
    [Abstract] [Full Text] [Related]

  • 4. Effect of destruction force on drug release from multiple unit controlled release dosage forms in humans.
    Katori N, Ma WS, Aoyagi N, Kojima S.
    Pharm Res; 1996 Oct; 13(10):1541-6. PubMed ID: 8899848
    [Abstract] [Full Text] [Related]

  • 5. Formulation and evaluation of sustained release paracetamol tablets.
    Ahmed M, Enever RP.
    J Clin Hosp Pharm; 1981 Mar; 6(1):27-38. PubMed ID: 7345094
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Controlled release of paracetamol from amylodextrin tablets: in vitro and in vivo results.
    van der Veen J, Eissens AC, Lerk CF.
    Pharm Res; 1994 Mar; 11(3):384-7. PubMed ID: 8008703
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Gastrointestinal physiology-regulated dogs for bioavailability evaluation of an oral controlled-release dosage form composed of pulsatile release granules.
    Sagara K, Yamada I, Matsuura Y, Kawata M, Shibata M.
    Biol Pharm Bull; 1996 Sep; 19(9):1184-8. PubMed ID: 8889038
    [Abstract] [Full Text] [Related]

  • 13. Preparation of controlled release tablets of TA-5707F with wax matrix type and their in vivo evaluation in beagle dogs.
    Yamakita H, Maejima T, Osawa T.
    Biol Pharm Bull; 1995 Jul; 18(7):984-9. PubMed ID: 7581255
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. High-amylose carboxymethyl starch matrices for oral sustained drug-release: in vitro and in vivo evaluation.
    Nabais T, Brouillet F, Kyriacos S, Mroueh M, Amores da Silva P, Bataille B, Chebli C, Cartilier L.
    Eur J Pharm Biopharm; 2007 Mar; 65(3):371-8. PubMed ID: 17275270
    [Abstract] [Full Text] [Related]

  • 16. A canine biorelevant dissolution method for predicting in vivo performance of orally administered sustained release matrix tablets.
    Walsh PL, Bothe JR, Bhardwaj S, Hu M, Nofsinger R, Xia B, Persak S, Pennington J, Bak A.
    Drug Dev Ind Pharm; 2016 Mar; 42(5):836-44. PubMed ID: 26339722
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Dosage form design and in vitro/in vivo evaluation of cevimeline extended-release tablet formulations.
    Tajiri S, Kanamaru T, Kamada M, Konno T, Nakagami H.
    Int J Pharm; 2010 Jan 04; 383(1-2):99-105. PubMed ID: 19747964
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.